This is made possible with a fundamental new technology called FISSEQ which simultaneously enables integration of high throughput sequencing, morphometric...
From Readcoor - Fri, 10 Mar 2017 17:16:04 GMT - View all Cambridge jobs

Funding Opportunity PAR-17-216 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for investigator-initiated clinical trials of natural products to treat clinical symptoms such as those associated with sleep disturbance, pain conditions, or some mental health conditions (e.g., mild to moderate depression, anxiety, and post-traumatic stress), or examine the effects of probiotics and other natural products on gut-microbiome interactions with the brain and/or immune system. All applications submitted under this FOA must be supported by sufficient preliminary data of bioavailability and documentation that the natural product produces a replicable and measurable biological signature (i.e., measure of the mechanism of action), whenever it is possible or practical to measure and used by the patient population of interest.

Funding Opportunity PAR-17-174 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages cooperative agreement applications for investigator-initiated multi-site clinical trials (Phase III and beyond) to study the effects of natural products in NCCIH designated areas of high research priority. Applicants should describe plans for a Clinical Coordinating Center to develop and implement the proposed multi-site clinical trial. The objective of the Clinical Coordinating Center is to provide the design scientific rationale and a comprehensive scientific and operational plan for the clinical trial. The Clinical Coordinating Center is expected to be responsible for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Clinical Coordinating Center applications submitted under this FOA will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism.

Funding Opportunity PAR-17-172 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase III and beyond) application submitted under PAR-17-174. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH.

Negotiable: Paramount Recruitment: Web Developer - Cambridge £30k - £39k DOE A very interesting opportunity has come available for a strong web developer to join a world-leading bioinformatics company in Cambridge. The position is focussing on front-middle layer web application developmen Cambridge, England

Negotiable: Paramount Recruitment: Bioinformatics Software Developer - Cambridge Salary - £50k (DOE) A great opportunity has come available for a Software Developer to join a fantastic company in Cambridge. You will be developing Bioinformatics pipelines and tools to integrate epigenetic Cambridge, England

Funding Opportunity PAR-17-173 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase III and beyond) application submitted under PAR-17-175. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH.

Funding Opportunity PAR-17-175 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated multi-site clinical trials (e.g. efficacy, effectiveness or pragmatic trials) to study the effects of mind and body interventions in NCCIH designated areas of high research priority. Clinical Coordinating Centers should develop and implement the proposed multi-site clinical trial. The objective of a Clinical Coordinating Center application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. Clinical Coordinating Center applications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Clinical Coordinating Center applications submitted under this FOA will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism.

Funding Opportunity PAR-17-215 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for investigator-initiated clinical trials of mind and body interventions in NCCIH-designated areas of high research priority. Applications submitted under this FOA are expected to propose a clinical trial to develop and test adaptive interventions; optimize the intervention by evaluating which element of a complex intervention are critical for changes in outcome; assessing whether the intervention can be delivered with fidelity across sites in preparation for a future multi-site trial; or collect additional preliminary data such as determining the duration or frequency of the intervention to be used in a future multi-site trial. It is important, therefore, to already have sufficient preliminary data that includes: demonstration of feasibility of recruitment and accrual of participants; demonstration of participant adherence to the intervention as well as retention of participants throughout the study; completion of final data collection from any related studies; and evidence that the intervention has promise of clinical benefit. This FOA is not intended to support multi-site efficacy or effectiveness trials, nor will it support trials to test mind and body interventions for the treatment or prevention of cancer.

Notice NOT-AI-17-018 from the NIH Guide for Grants and Contracts

Salary above market: D. E. Shaw Research: D. E. Shaw Research is seeking outstanding scientists with expertise in structure-based drug design or related areas to join our New York–based team. New York City, New York (US)

GBP36000.00 - GBP40000.00 per annum + bens: Hays Recruitment: Bioinformatician with good Python, R, pipeline and database skills for growing genomics company in Cambridge Your new company Is a rapidly growing genomic medicine focused company providing solutions to patients and doctors that make a real difference t Cambridge, England

Funding Opportunity PAR-17-214 from the NIH Guide for Grants and Contracts. The National Institute on Aging invites applications specific to the analysis of genome-wide association studies and whole-genome and related sequencing data generated under PAR-16-406.

Notice NOT-DA-17-009 from the NIH Guide for Grants and Contracts

Notice NOT-GM-17-003 from the NIH Guide for Grants and Contracts

Your background should combine understanding and expertise in genetics/genomics, bioinformatics, and biomedical research with experience in project management....
From Celmatix - Fri, 10 Mar 2017 06:03:10 GMT - View all New York jobs

Bachelor’s Degree in Electrical Engineering, Computer Science, Bioengineering, Biomedical, Bioinformatics or related field....
From Proteus Digital Health - Fri, 10 Mar 2017 04:09:26 GMT - View all Redwood City jobs

Must have a proven track record across a wide range computational biologic methods, ranging from computational systems biology through computational...
From Merck - Fri, 10 Mar 2017 04:05:04 GMT - View all Cambridge jobs

Neg: Seltek Consultants: A growing business in Finland is looking for a senior bioinformatics specialist to lead and manage projects. This will include communication with c... Finland (FI)

This is made possible with a fundamental new technology called FISSEQ which simultaneously enables integration of high throughput sequencing, morphometric...
From Readcoor - Thu, 09 Mar 2017 23:13:27 GMT - View all Cambridge jobs